News
-
-
-
MOODY’S ASSIGNS FIRST-TIME A3 IFSR TO FIDELIDADE MACAU
2021-01-22
Macao, January 12, 2021 – Yesterday, Moody’s Investors Service (Moody’s) assigned an A3 insurance financial strength rating (IFSR) to Fidelidade Macau - Insurance Company Limited (Fidelidade Macau), an important achievement that reflects the company’s strong underwriting profitability and capitalization, along with its prudent investment allocation. The outloo
-
-
-
-
Henlius Daratumumab Biosimilar Received IND Approval from NMPA
2021-01-13
-
-
-
-
Enjoy French Snow Holiday, Reinventing Togetherness with a New Start – new snow mountain experiences in Club Med Yabuli
2020-12-30
-
-
-
-
NMPA Has Accepted The NDA of HLX01 (Rituximab Injection) for the Treatment of Rheumatoid Arthritis
2020-12-17
-
-
-
-
Henlius Adalimumab Biosimilar 汉达远® Approved by NMPA
2020-12-10
-
-
-
-
Hauck & Aufhäuser takes first step towards digital assets
2020-10-09
-
-
-
-
Investigational New Drug Application of Henlius SARS-CoV-2 Neutralizing Antibody HLX70 Approved by US FDA
2020-10-05
-
-
-
-
Henlius Released Phase 3 Study Data of its Bevacizumab Biosimilar HLX04 at CSCO 2020
2020-09-22
-
-
-
-
Opening of Hauck Investment Management (Shanghai) Co.
2020-09-22
-
